Theodor H. Heinrichs has been named chairman of Synbiotics Corp., succeeding Donald K. Ballman, who remains on the board. Heinrichs is senior investment partner at Hambrecht & Quist Inc., a San Francisco-based investment banking and venture capital firm.
